W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers
Clinical trial NCT01915758 · COMPLETED
Trial details
- NCT number
- NCT01915758
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-21
- Primary completion
- 2009-02-20
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.